QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome

Takahiko Nagamine,Takeshi Watanabe,Akira Toyofuku
DOI: https://doi.org/10.1097/wnf.0000000000000583
2024-03-13
Clinical Neuropharmacology
Abstract:Burning mouth syndrome (BMS) is an intractable chronic pain disorder characterized by a burning sensation without organic abnormalities in the oral mucosa. Amitriptyline may be effective for BMS or, conversely, may exacerbate pain. QTc is necessary for monitoring psychotropic adverse effects, but it is not known if it is a predictor of efficacy for BMS. We investigated the efficacy of amitriptyline in BMS and its effect on QTc.
pharmacology & pharmacy,clinical neurology
What problem does this paper attempt to address?